Chester County News and Community Website
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the issuance of non-qualified stock option awards to two newly hired employees as part of an inducement to join the company. …
Context Therapeutics Grants Stock Options to New Employees Read More PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced its participation in several upcoming investor conferences.
Context Therapeutics to Showcase at Top 2025 Investor Conferences Read More PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX has announced that the first patient has been dosed in its Phase 1 clinical trial evaluating CTIM-76. This experimental treatment is a …
Breakthrough in Cancer Treatment? Context Therapeutics Launches Phase 1 Trial for CLDN6-Targeted Therapy Read More PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Andy Pasternak as Chairman of its Board of Directors, following the departure of Richard Berman, who stepped down …
Context Therapeutics Welcomes Andy Pasternak as New Chairman of the Board Read More